A systematic review and meta-analysis of prognostic indicators in patients with head and neck malignancy treated with immune checkpoint inhibitors
Dengxiong Kang, Siping Liu, Xin Yuan, Shenxiang Liu, Zhengrong Zhang, Zhilian He, Xudong Yin, Haiyan Mao
Topics & Concepts
MedicineInternal medicineOncologyHead and neck squamous-cell carcinomaImmunotherapyGrading (engineering)MalignancyDurvalumabHematologyHead and neck cancerNivolumabRadiation therapyCancerEngineeringCivil engineeringInflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and BiomarkersHead and Neck Cancer Studies